Brief: Integer Outlook FY Revenue USD 1,850-1,876 Million

Integer Holdings

24/07/2025 13:10

Repeats to link to corrected alerts

Overview

Integer fiscal Q2 sales rise 11% to $476 mln, beating analyst expectations

Adjusted EPS for fiscal Q2 meets analyst estimates, per LSEG data

Company raises 2025 adjusted operating income and EPS outlook at the midpoint

Outlook

Integer sees 2025 adjusted EPS of $6.25 to $6.51, a growth of 18%-23%

Company expects 2025 adjusted operating income growth of 12%-16%

Integer projects 2025 sales between $1.85 bln and $1.88 bln

Company anticipates 2025 cash flow from operations of $235 mln to $255 mln

Result Drivers

CARDIO & VASCULAR - Sales rose 24% driven by new product ramps and acquisitions

NEUROMODULATION - Growth supported by emerging customers with PMA (pre-market approval) products

PORTABLE MEDICAL EXIT - Sales in Other Markets fell 38% due to planned exit

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Beat
$476 mln
$464.40 mln (9 Analysts)
Q2 Adjusted EPS
Meet
$1.55
$1.55 (8 Analysts)
Q2 Adjusted Net Income
Miss
$55 mln
$55.10 mln (7 Analysts)

Press Release: ID:nGNX79x8RR

 (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)